UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 407

Sortiert nach

A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery

Journal of controlled release, 2017-10, Vol.264, p.102-111

2017

Link zum Volltext

Verfügbarkeit prüfen

Doxil® — The first FDA-approved nano-drug: Lessons learned

Journal of controlled release, 2012-06, Vol.160 (2), p.117-134

Barenholz, Yechezkel (Chezy)

2012

Link zum Volltext

Verfügbarkeit prüfen

Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

Journal of controlled release, 2019-01, Vol.294, p.376-389

2019

Link zum Volltext

Verfügbarkeit prüfen

An overview of clinical and commercial impact of drug delivery systems

Journal of controlled release, 2014-09, Vol.190, p.15-28

2014

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

Journal of controlled release, 2015-02, Vol.199, p.145-155

2015

Link zum Volltext

Verfügbarkeit prüfen

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery

Journal of controlled release, 2014-01, Vol.174, p.98-108

2014

Link zum Volltext

Verfügbarkeit prüfen

cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo

Journal of controlled release, 2016-07, Vol.233, p.29-38

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity

Journal of controlled release, 2016-01, Vol.222, p.56-66

2016

Link zum Volltext

Verfügbarkeit prüfen

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome

Journal of controlled release, 2016-01, Vol.221, p.1-8

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Journal of controlled release, 2015-12, Vol.220 (Pt A), p.275-286

2015

Link zum Volltext

Verfügbarkeit prüfen

Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy

Journal of controlled release, 2018-07, Vol.282, p.46-61

2018

Link zum Volltext

Verfügbarkeit prüfen

Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging

Journal of controlled release, 2016-05, Vol.229, p.183-191

2016

Link zum Volltext

Verfügbarkeit prüfen

Magnetic field triggered drug release from polymersomes for cancer therapeutics

Journal of controlled release, 2013-08, Vol.169 (3), p.165-170

2013

Link zum Volltext

Verfügbarkeit prüfen

pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells

Journal of controlled release, 2016-06, Vol.232, p.9-19

2016

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy

Journal of controlled release, 2017-07, Vol.258, p.43-55

2017

Link zum Volltext

Verfügbarkeit prüfen

Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA

Journal of controlled release, 2013-11, Vol.171 (3), p.349-357

2013

Link zum Volltext

Verfügbarkeit prüfen

Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese

Journal of controlled release, 2005-05, Vol.104 (2), p.271-288

2005

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy

Journal of controlled release, 2019-02, Vol.295, p.153-163

2019

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors

Journal of controlled release, 2016-03, Vol.225, p.301-313

2016

Link zum Volltext

Verfügbarkeit prüfen

Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy

Journal of controlled release, 2017-10, Vol.264, p.89-101

2017

Link zum Volltext

Verfügbarkeit prüfen

Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation

Journal of controlled release, 2015-01, Vol.197, p.29-40

2015

Link zum Volltext

Verfügbarkeit prüfen

A small molecule nanodrug consisting of amphiphilic targeting ligand–chemotherapy drug conjugate for targeted cancer therapy

Journal of controlled release, 2016-05, Vol.230, p.34-44

2016

Link zum Volltext

Verfügbarkeit prüfen

Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release

Journal of controlled release, 2013-08, Vol.169 (3), p.171-179

2013

Link zum Volltext

Verfügbarkeit prüfen

Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy

Journal of controlled release, 2016-12, Vol.244 (Pt B), p.326-335

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression

Journal of controlled release, 2016-06, Vol.232, p.131-142

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 407

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Controlled Release

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(407)

Publikationsform

Artikel
(407)

Sprache

Englisch
(407)
Japanisch
(101)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Chemistry
(388)
Chemistry, Multidisciplinary
(388)
Life Sciences & Biomedicine
(388)
Pharmacology & Pharmacy
(388)
Physical Sciences
(388)
Science & Technology
(388)
Doxorubicin - Administration & Dosage
(384)
Animals
(307)
Humans
(278)
Antibiotics, Antineoplastic - Administration & Dosage
(252)
Doxorubicin
(215)
Cell Line, Tumor
(195)
Mice
(179)
Biological And Medical Sciences
(156)
Medical Sciences
(156)
Pharmacology. Drug Treatments
(156)
General Pharmacology
(155)
Pharmaceutical Technology. Pharmaceutical Industry
(155)
Doxorubicin - Pharmacokinetics
(151)
Female
(148)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(407)
IngentaConnect
(407)
Elsevier ScienceDirect Journals Complete
(407)
Journals@Ovid Full Text
(404)
IngentaConnect Journals
(5)

Menü

Weitere Dienste

Einstellungen

A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery

Doxil® — The first FDA-approved nano-drug: Lessons learned

Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

An overview of clinical and commercial impact of drug delivery systems

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery

cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo

Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy

Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging

Magnetic field triggered drug release from polymersomes for cancer therapeutics

pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy

Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA

Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese

Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy

Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors

Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy

Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation

A small molecule nanodrug consisting of amphiphilic targeting ligand–chemotherapy drug conjugate for targeted cancer therapy

Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release

Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy

Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression

Aktive Filter

Suchergebnisse filtern